TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pensa Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/03 | 2021/12 | 2020/12 |
Turnover |
32,130
|
38,271
|
23,506 |
Financial expenses |
101
|
1
|
147 |
Earnings before taxes |
-3,722
|
1,049
|
460 |
EBITDA |
-3,345
|
982
|
619 |
Total assets |
28,735
|
28,397
|
36,936 |
Current assets |
22,612
|
17,286
|
28,080 |
Current liabilities |
10,318
|
6,818
|
14,286 |
Equity capital |
18,417
|
21,579
|
22,650 |
- share capital |
1,005
|
975
|
1,048 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/03 | 2021/12 | 2020/12 |
Solvency |
64.1%
|
76.0%
|
61.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
-11.6%
|
2.7%
|
2.0% |
Return on assets (ROA) |
-12.6%
|
3.7%
|
1.6% |
Current ratio |
219.2%
|
253.5%
|
196.6% |
Return on equity (ROE) |
-20.2%
|
4.9%
|
2.0% |
Change turnover |
-7,293
|
16,389
|
2,734 |
Change turnover % |
-19%
|
75%
|
13% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/03 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.